|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/705 | |
| C07K 16/28 | |||
| G01N 33/50 | |||
| C07K 14/47 | |||
| C12N 5/0783 |
| (11) | Patento numeris | 3392270 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18175738.6 |
| Europos patento paraiškos padavimo data | 2012-09-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161535086 P | 2011-09-15 | US |
| (72) |
ROBBINS, Paul F., US
ROSENBERG, Steven A., US
ZHU, Shiqui, US
FELDMAN, Steven A., US
MORGAN, Richard A., US
|
| (73) |
The United States of America, as Represented by the Secretary Department of Health and Human Services,
National Institutes of Health Office of Technology Trensfer 6011 Executive Boulevard Suite 325 Msc 7660, Bethesda, MD 20852-7660,
US
|
| (54) | T CELL RECEPTORS RECOGNIZING HLA-A1- OR HLA-CW7-RESTRICTED MAGE |
| T CELL RECEPTORS RECOGNIZING HLA-A1- OR HLA-CW7-RESTRICTED MAGE |